213 related articles for article (PubMed ID: 8659100)
1. Transforming activity of the E6 gene of HPV-11gt in NIH 3T3 and REF 52 cells: correlation with the level of E6 transcription.
Trujillo JM; Mounts P
Virology; 1996 Jun; 220(1):1-9. PubMed ID: 8659100
[TBL] [Abstract][Full Text] [Related]
2. The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA.
Stöppler MC; Straight SW; Tsao G; Schlegel R; McCance DJ
Virology; 1996 Sep; 223(1):251-4. PubMed ID: 8806560
[TBL] [Abstract][Full Text] [Related]
3. The expression levels of the human papillomavirus type 16 E7 correlate with its transforming potential.
Liu Z; Ghai J; Ostrow RS; Faras AJ
Virology; 1995 Feb; 207(1):260-70. PubMed ID: 7871737
[TBL] [Abstract][Full Text] [Related]
4. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
5. Expression of the human papillomavirus E7 oncogene during cell transformation is sufficient to induce susceptibility to lysis by activated macrophages.
Banks L; Moreau F; Vousden K; Pim D; Matlashewski G
J Immunol; 1991 Mar; 146(6):2037-42. PubMed ID: 1848576
[TBL] [Abstract][Full Text] [Related]
6. The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene.
Vousden KH; Doniger J; DiPaolo JA; Lowy DR
Oncogene Res; 1988 Sep; 3(2):167-75. PubMed ID: 2852339
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells.
Pim D; Storey A; Thomas M; Massimi P; Banks L
Oncogene; 1994 Jul; 9(7):1869-76. PubMed ID: 8208532
[TBL] [Abstract][Full Text] [Related]
8. The products of the E5, E6, or E7 open reading frames of RhPV 1 can individually transform NIH 3T3 cells or in cotransfections with activated ras can transform primary rodent epithelial cells.
Ostrow RS; Liu Z; Schneider JF; McGlennen RC; Forslund K; Faras AJ
Virology; 1993 Oct; 196(2):861-7. PubMed ID: 8396814
[TBL] [Abstract][Full Text] [Related]
9. Transformation assays for HPV oncoproteins.
Massimi P; Banks L
Methods Mol Med; 2005; 119():381-95. PubMed ID: 16350412
[TBL] [Abstract][Full Text] [Related]
10. Transfer of the E6 and E7 genes of human papillomavirus type 18 into human epithelial cells via recombinant retrovirus infection.
Wu CJ; Chang KS; Chang YS
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Aug; 30(3):123-34. PubMed ID: 10592818
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activation by the E6 gene product of human papillomavirus type 16.
Klingelhutz AJ; Foster SA; McDougall JK
Nature; 1996 Mar; 380(6569):79-82. PubMed ID: 8598912
[TBL] [Abstract][Full Text] [Related]
12. The E6 gene of human papillomavirus type 16 is sufficient for transformation of baby rat kidney cells in cotransfection with activated Ha-ras.
Liu Z; Ghai J; Ostrow RS; McGlennen RC; Faras AJ
Virology; 1994 Jun; 201(2):388-96. PubMed ID: 8184549
[TBL] [Abstract][Full Text] [Related]
13. Effect of human papillomavirus type 16 E6 and E7 oncogenes on the activity of the transforming growth factor-beta2 (TGF-beta2) promoter.
Murvai M; Borbély AA; Kónya J; Gergely L; Veress G
Arch Virol; 2004 Dec; 149(12):2379-92. PubMed ID: 15290353
[TBL] [Abstract][Full Text] [Related]
14. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
[TBL] [Abstract][Full Text] [Related]
15. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of transcriptional activation by the bovine papillomavirus type 1 E6.
Chen JJ; Hong Y; Androphy EJ
Virology; 1997 Sep; 236(1):30-6. PubMed ID: 9299614
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification.
Hiller T; Poppelreuther S; Stubenrauch F; Iftner T
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1262-7. PubMed ID: 16835321
[TBL] [Abstract][Full Text] [Related]
18. Functional interaction of p53 with HPV18 E6, c-myc and H-ras in 3T3 cells.
Chen TM; Defendi V
Oncogene; 1992 Aug; 7(8):1541-7. PubMed ID: 1321402
[TBL] [Abstract][Full Text] [Related]
19. Combined oral carcinogenicity of HPV-16 and benzo(a)pyrene: an in vitro multistep carcinogenesis model.
Park NH; Gujuluva CN; Baek JH; Cherrick HM; Shin KH; Min BM
Oncogene; 1995 Jun; 10(11):2145-53. PubMed ID: 7784058
[TBL] [Abstract][Full Text] [Related]
20. Viral oncogenes accelerate conversion to immortality of cultured conditionally immortal human mammary epithelial cells.
Garbe J; Wong M; Wigington D; Yaswen P; Stampfer MR
Oncogene; 1999 Apr; 18(13):2169-80. PubMed ID: 10327063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
